^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

Opal

i
Other names: Opal, PD-1xCD137L fusion protein
Company:
Cullinan Oncology
Drug class:
PD1 inhibitor, CD137 agonist
Related drugs: